Page 33 - Deleware Medical Journal - September/October 2019

ORIGINAL RESEARCH
CONTRIBUTING AUTHORS
■ TRISHA PASCALL-LOPEZ, DO is a hospitalist with Sentara Medical Group and former internal medicine resident at Christiana Care Health System.
■ NICHOLAS PETRELLI, MD is the Bank of America Endowed Medical Director of Helen F. Graham Cancer Center & Research institute at Christiana Care Health System. He is a previous President of the Society of Surgical Oncology.
■ ROBERT E. HALL-MCBRIDE, CTR is a Project Manager
at the Tumor Registry/Oncology Data Center, Helen F. Graham Cancer Center & Research institute at Christiana Care Health System. He is a member of the Delaware Cancer Consortium and Delaware Cancer Registry Advisory Committee.
■ MICHAEL GUARINO, MD is a medical oncologist at Helen F. Graham Cancer Center & Research Institute at Christiana Care Health System. He is also Director of the Pharmaceutical Clinical Trials Program and works with Medical Oncology Hematology Consultants.
REFERENCES
1. Quinn T Ostrom, Haley Gittleman, Gabrielle Truitt, Alexander Boscia, Carol Kruchko, Jill S Barnholtz-Sloan; CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011–2015, Neuro-Oncology. 2018; 20, Issue suppl 4, 1, iv1–iv86.
2. R. Stupp, on behalf of the ESMO Guidelines Working Group, M. Brada, on behalf of the ESMO Guidelines Working Group, M. J. van den Bent, on behalf of the ESMO Guidelines Working Group, J.-C. Tonn, on behalf of the ESMO Guidelines Working Group, G. Pentheroudakis, on behalf of the ESMO Guidelines Working Group; High-grade Glioma: ESMO Clinical Practice Guidelines for Diagnosis, Treatment, and Follow-up, Annals of Oncology, 2014; 25, Issue suppl 3, iii93–iii101.
3. Gately, L., McLachlan, SA., Philip, J. Ruben J, Dowling A. Long-term Survivors of Glioblastoma: A Closer Look. J Neurooncol. 2018; 136: 155- 162.
4. Burton E, Ugiliweneza B, Woo S, Skirboll S, Boaky M. A Surveillance, Epidemiology and End Results — Medicare Data Analysis of Elderly Patients With Glioblastoma Multiforme: Treatment Patterns, Outcomes and Cost. Mol Clin Oncol. 2015; 3(5):971-978.
5. Johnson, D.R. & O’Neill, B.P. Glioblastoma Survival in the United States Before and During the Temozolomide Era. J Neurooncol, 2012 ;107: 359- 364.
6. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma. N Engl J Med 2005;352:987-96.
CAISE Benefits has over 50 years of combined experience. We are independant Medicare Consultants and WE DO NOT CHARGE FEES. Our goal is to show your patients the options available and give them the information needed to understand the ever changing world of Medicare.
We can also cut the bottom line to reduce your health insurance premiums, let us quote your group insurance.
www.caisebenefits.com
HARDCASTLE GALLERY
5714 KENNETT PIKE CENTREVILLE, DE 19807
OPENING 5:30-8:30
SHOW CONTINUES UNTIL OCT 31 302.655.5230 • www.hardcastlegallery.com
Del Med J | September/October 2019 | Vol. 91 | No. 5
225